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ABSTRACT
In recent years, zebrafish, and to a lesser extent medaka, have
become widely used small animal models for human diseases. These
organisms have convincingly demonstrated the usefulness of fish for
improving our understanding of the molecular and cellular
mechanisms leading to pathological conditions, and for the
development of new diagnostic and therapeutic tools. Despite the
usefulness of zebrafish and medaka in the investigation of a wide
spectrum of traits, there is evidence to suggest that other fish species
could be better suited for more targeted questions. With the
emergence of new, improved sequencing technologies that enable
genomic resources to be generated with increasing efficiency and
speed, the potential of non-mainstream fish species as disease
models can now be explored. A key feature of these fish species is
that the pathological condition that they model is often related to
specific evolutionary adaptations. By exploring these adaptations,
new disease-causing and disease-modifier genes might be identified;
thus, diverse fish species could be exploited to better understand the
complexity of disease processes. In addition, non-mainstream fish
models could allow us to study the impact of environmental factors,
as well as genetic variation, on complex disease phenotypes. This
Review will discuss the opportunities that such fish models offer for
current and future biomedical research.
KEY WORDS: Fish model, Cancer, Evolutionary mutant model,
Natural variation
Introduction
The usefulness of biological models in providing insight into disease
mechanisms, diagnostics and treatment is undisputable. Indeed, the
list of ground-breaking insights into human diseases and highly
efficient drugs developed based on animal studies is ever-growing.
Although basic biomedical research relies on a variety of biological
model organisms, clinicians more closely involved in applied
biomedicine tend to trust the models that are most similar
physiologically to humans. This has given mammals, particularly
rodents, an undisputed supreme position as a model system for
human disease, dating back to the 1920s. The laboratory mouse has
become the most widely used model principally owing to the ease
by which it can be genetically modified.
More recently, there has also been an increasing appreciation of
fish as human disease models. Admittedly, your guest in a restaurant
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looks distinct from the fish on his/her plate; however, scientists note
only minor differences at the level of biological organization.
Although fish diverged from humans more than 400-million years
ago, there are enough commonalities to justify conducting research
that is relevant to humans in these animals. At the molecular level,
there are very few differences. For instance, the human HRAS gene,
which is one of the most frequently mutated genes in cancer, shares
over 95% identity with the corresponding gene in medaka. The few
amino acid differences cluster in the carboxy terminus, far away
from the enzymatic core of the protein, in which the human
oncogenic mutations are found (Fig. 1). For biomedical research,
fish provide a number of exceptional advantages: laboratory fish
models are small and can be bred and maintained in large numbers
easily and at low cost. They offer the opportunity to combine the
analytical clarity of developmental biology with the power of
genetics, and transgenic lines can be easily and quickly produced.
Fish are also amenable to high-throughput approaches such as
whole-genome mutagenesis or chemical library drug screens.
This Review does not discuss in detail the advantages, successes
and promises of the zebrafish as the most prominent and most
widely used fish model. Rather, it is an appeal that the research
community does not put all of its eggs in one basket, and instead
considers the opportunities that lie in the great biodiversity of
different fish species. This plea has its origin in issues that were
brought to light shortly after the whole human genome sequence
was published, followed closely by the genome sequences of most
model organisms, and an explosion of discovery relating to single-
nucleotide polymorphisms, gene copy-number variation and
quantitative trait loci (QTL). At the beginning of this ‘post-genomic’
era, several authors (Albertson et al., 2009; Bolker, 2012; Davis,
2004) pointed out that, despite their undisputable usefulness, the so-
called ‘genetically domesticated’ model organisms have their
limitations when it comes to the study of pleiotropy, multigenic
inheritance, variable expressivity and variable penetrance of
phenotypes. Also, natural environmental influences, which can
profoundly modulate a phenotype, might be difficult or impossible
to study in the indigenized, laboratory-adjusted classical models,
because such environment-genotype interactions can be easily lost
in selective breeding. Here, I first briefly discuss the mainstream
genetically domesticated small aquarium fish models zebrafish and
medaka. I then discuss why and how several other fish species are
particularly advantageous for studying questions related to medical
conditions that are more difficult to address in genetically
domesticated models.
Zebrafish and medaka: the major and mainstream models
The zebrafish is the canonical fish model for studying human disease.
A large and steadily growing community relies heavily on this fish,
courtesy of its excellent features, which have been highlighted in
many reviews (e.g. Amatruda and Patton, 2008; Jing and Zon, 2011;
Meijer and Spaink, 2011; Mione and Trede, 2010; Renshaw and



















Trede, 2012; Santoriello and Zon, 2012; Zon and Peterson, 2005).
Although much less well-known and used only by a small, but
steadily growing, community of researchers, the medaka Oryzias
latipes (also known as the Japanese ricefish) can be regarded as a
complementary model and is equivalent in many ways to the most
common fish model (Wittbrodt et al., 2002). Like the similar-sized
zebrafish, the medaka has a short generation time, is easy to breed in
large numbers in the laboratory and produces transparent eggs, which
make it easy to follow embryonic development.
One motivation to build up the medaka as a second laboratory fish
model in parallel to the zebrafish is the complementarity argument.
During their evolutionary history, teleost fish have undergone a
whole-genome duplication leading to the situation of fish having
two copies of many genes of which other vertebrates have only one
(Amores et al., 1998; Braasch and Postlethwait, 2012; Meyer and
Schartl, 1999; Postlethwait et al., 2000). This often manifests in
altered gene expression patterns or protein functions, such that the
complement of the expression domains or protein functions of both
fish paralogs are equivalent to the single ortholog in other
vertebrates. For instance, if a mouse gene is expressed in liver and
kidney, one copy of the equivalent separate fish gene would be
expressed in liver and the second copy would be expressed in
kidney. This evolutionary process, which has been termed
subfunction partitioning or subfunctionalization (Force et al., 1999),
has far-reaching implications for functional studies of such genes.
For example, when a mutation in mouse inactivates a gene that has
a role in early development in addition to an adult organ-specific
function, it becomes impossible to study the function of the adult
organ in such mutants. In fish, both functions can be partitioned
between duplicates, making it possible to separate both phenotypes.
Thus, the teleost whole-genome duplication provides unique
opportunities for studies on genes involved in disease development.
Because there is a considerable amount of lineage-specific duplicate
retention (meaning that one gene pair is retained and
subfunctionalized in the zebrafish lineage, but not in medaka – and
vice versa), the availability of more than one fish laboratory model
will allow this situation to be fully exploited. In addition, gene
function redundancy, which interferes with gene knockdown and
knockout approaches, could differ between zebrafish and medaka,
i.e. a paralogous gene resulting from the teleost whole-genome
duplication event could take over the function of the mutagenized
target gene, but, owing to differential duplicate retention, such
redundancy might occur in one lineage but not in the other.
Both medaka and zebrafish provide a number of powerful
laboratory tools. Transgenic fluorescent marker lines that allow these
small aquarium fish models to be used for bioimaging have been
developed in abundance. Systematic large-scale mutagenesis screens
have led to a vast collection of mutants. The genomes of both fish are
sequenced (Howe et al., 2013; Kasahara et al., 2007) and large
genomic resources have been built up. For functional studies, a large
toolbox exists in zebrafish and medaka: downregulation of gene
expression during early development can be achieved by morpholinos,
and gene knockout can be mediated by sophisticated genome-editing
technologies such as zinc finger nucleases and TALENs. Furthermore,
resource centers (NBRP for medaka, http://www.shigen.nig.ac.jp/
medaka/; ZIRC for zebrafish, http://zebrafish.org/zirc/home/
guide.php) have been established, from where mutants, natural and
transgenic strains, and cDNA and genomic clones can be obtained.
A plethora of zebrafish and medaka disease models have been
generated, making the zebrafish in particular the ‘laboratory mouse’
of fish models. Three common approaches have been used to
generate these models. First, numerous mutational screens for
developmental defect mutant embryos have been performed, and
many of these brought to light phenotypes that resemble disease
symptoms or affected genes that were already known to play a role
in certain pathological conditions. Every mutant affecting the
development of a certain cell type, tissue or organ can be used to
better understand not only the physiology of normal development
but also the pathological processes underlying congenital
malformations, or chronic or degenerative diseases associated with
those cells. Second, and in analogy to most mouse disease models,
transgenic fish have been produced that express genes with known
disease-related mutations. Third, a tool that is particularly easy to
use in the translucent fast-developing embryos is gene knock-down
with chemically modified short antisense oligonucleotides
(‘morpholinos’) that are injected into embryos at the one-cell stage.
Morpholinos can interfere with the expression of almost any gene
of interest during embryonic and early larval development.
Overall, the existing fish models have provided outstanding
opportunities for deciphering and understanding disease processes
and identifying new molecular markers and therapeutic targets.
Another key feature is the potential to perform high-throughput drug
screens of chemical libraries using fish models of disease. Fish
embryos and larvae can simply be immersed in medium containing
the compounds and scored for phenotypic effects under a binocular
microscope. Similarly, effects on disease markers can be assessed
using high-throughput RNA in situ hybridization or protein
immunostaining. Several such chemical screens, in which embryos
that exhibit a certain disease-related phenotype are exposed in
multiwell plates to tens of thousands of different compounds, have
already been performed and led to the identification of promising
candidate molecules (Santoriello and Zon, 2012).
Thus, the success of zebrafish and medaka as animal models for
human diseases is well documented and widely accepted. Without
questioning in any way the usefulness of the current approaches that
exploit these fish, the present strategies have some notable
limitations. In particular, zebrafish has been established primarily as
an embryological or larval model for understanding vertebrate
developmental biology. Many human diseases, however, occur in
the adult or aging organism. This weakness becomes even more
prominent when considering degenerative diseases. Studies aiming
to better understand a neurodegenerative process might be more
difficult to interpret when the disease is modeled in a mutant embryo
that does not fully develop this neural structure.
In transgenic models that express a disease-associated gene, the
human gene carrying the human mutation is generally used. This has
in most cases been sufficient to produce a phenotype that









Fig. 1. Sequence comparison of the human and fish (medaka) HRAS
proteins. Below the alignment, identical amino acids are represented by an
asterisk (*), a semi-conservative change is indicated by a dot (.) and a
conservative change is indicated by a colon (:). The most frequent mutations
in the STPase enzymatic active site of the protein in human cancers are
















satisfactorily mimics the human phenotype. However, even highly
conserved proteins might have acquired subtle amino acid changes
because of their fish- or human-lineage-specific coevolution with
interacting or regulatory protein partners. Such interactive functions
might escape detection during analysis (Fig. 2). This advocates for
more subtle transgenic models in which, for example, the human
disease mutation is introduced into the homologous fish gene.
The concept of the ‘evolutionary mutant model’
Although zebrafish and medaka are the mainstream models, other
fish models are now emerging from the backwaters of science,
thanks to the perception that they are useful as ‘evolutionary mutant
models’ for complex human diseases. This concept was first
introduced by Craig Albertson, John Postlethwait and colleagues
(Albertson et al., 2009). It is based on the awareness that evolution
by adaptation to a specific environment has resulted in species or
populations of many animal groups (including fish) that exhibit
phenotypes closely resembling or mimicking human diseases. But
are these other fish species – which are often experimentally less
tractable than established models – useful for understanding human
diseases? Moreover, can they be used to generate knowledge that
cannot be more easily obtained from zebrafish and medaka?
Several lines of evidence support the idea that other fish species are
valuable in disease research. For example, it has been argued that the
mutations identified in forward genetic screens in zebrafish and
medaka are biased. The screens conducted thus far have
predominantly recovered mutant animals at the earliest developmental
stage, when the gene displays an essential function. This often
precludes studying disease phenotypes that develop later in life. By
contrast, the disease-mimicking alterations in the evolutionary models
manifest mostly in the adult or at least persist during adulthood.
Screens can also be biased towards mutations in the coding regions
of genes, because the resulting phenotypes are more readily identified
and show less variance. However, many mutations that cause a
disease or increase disease susceptibility are found in the regulatory
regions of genes (Horn et al., 2013; Huang et al., 2013; Lauderdale et
al., 2000; Lettice et al., 2003; Loots et al., 2005; Sabherwal et al.,
2007; Velagaleti et al., 2005). The genes that are involved in the
phenotype that resembles the human condition in evolutionary models
should, like the human genes, not be biased for coding mutations, and
are expected to also harbor regulatory changes.
Mutagenesis screens often identify phenotypes that are more
severe than the human disease they model. Traditional laboratory
mutagenesis screens were set up to destroy genes; thus, the
uncovered mutations strongly affect gene function and lead to severe
phenotypes. For practical reasons, a stereotypical and strong
phenotype in all individuals is desirable. Human diseases, however,
can be ordered on a gradient from being very simple to extremely
complex. At the low end are monogenic traits with little phenotypic
variation in individuals that have the same disease allele. Many of
the induced mutant models and transgenic models fall into this
category. Other human diseases are caused by alleles of major effect,
but the expression of such alleles is variable and considerably
affected by modifier genes, i.e. the genetic background of the
individual is important. At the high end of the spectrum are
polygenic diseases such as cancer or cardiovascular disorders, for
which the severity of the disease depends on the genotype of the
patient at multiple loci, in addition to environmental influences. This
complexity of human diseases, which is hard to capture
experimentally and far from being understood, might be mirrored
better by the evolutionary mutant models because the natural
variation on the genes that correspond to human disease genes has
created genetic diversity in a similar way as in humans.
In their seminal paper in 2009 (Albertson et al., 2009),
Postlethwait and colleagues presented several examples for
evolutionary mutant fish models. These will also be presented
briefly here and complemented by additional natural models for
human disease (summarized in Table 1). Generally speaking, the
disease models can be categorized into different classes. One
consists of evolutionary mutants in which the disease state is
adaptive; the other encompasses fish that are afflicted with the same
disease as humans, thus developing a true illness. A common feature
across the disease models is allelic variation. Because of allelic
variation, the same species of fish can provide completely
independent models that fall into either the first or second class of
disease models. Several examples of models within each of the two
categories are described in the following sections.
Models of adaptive disease phenotypes
Antarctic fish: models of osteoporosis and anemia
Paradigmatic examples for class I evolutionarily adapted models are
found among the Antarctic fish (suborder Notothenioidei) (Fig. 3).
In several species from multiple families of this suborder, changes
in the musculoskeletal system occurred during evolution. To
increase buoyancy, some of these fish display considerably
decreased bone mineralization (Albertson et al., 2010; Kock, 2005).
A reduction in bone mineral density is associated with a very
common human condition known as osteopenia. It progresses
frequently to the severe bone disease osteoporosis, which affects
almost half of all women over 50 years of age as a result of changes
in hormone levels. Osteoporosis is also seen in a substantial
proportion of elderly men. The disease is characterized by bone
microarchitecture deterioration and reduced bone mineral density,
and these changes increase the risk of bone fracture. The
identification and functional characterization of the notothenioid
genes that are responsible for the natural osteopenia in these fish will
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Fig. 2. Schematic representation of the process of protein divergence in
different lineages after separation from a common ancestor. Because
interacting proteins evolve independently, the molecular structure of the
interaction interface changes in both partners so that they still fit (i.e. co-
evolution occurs), but this will not necessarily affect the same amino acids.
Eventually, protein A from one lineage is unable to properly interact with
protein B from the other lineage (despite having fully retained its biochemical
function, e.g. as an enzyme or G-protein). This process is known to
evolutionary biologists as the Muller-Dobshansky-Bateson phenomenon. The
divergence of interacting proteins can have an impact on studying the effect

















contribute to a better understanding of the mechanisms that are
involved in the regulation of bone mineral density and that are
impaired in human bone diseases.
Additional buoyancy has been achieved in Antarctic fish by
increasing lipid deposits in tissues and inner organs. In humans,
lipidoses are a group of inherited metabolic diseases in which
harmful levels of lipids accumulate in various organs, causing
permanent cellular and tissue damage over time. Again, studies of
notothenioid fish might help us to better understand the pathology
of these human disorders.
The white-blooded icefish (Channichthyidae), a subtype of
notothenioid fish, provide a model for human anemias. These are
diseases characterized by a reduction in erythrocyte numbers or
hemoglobin in the blood. The consequence is a potentially harmful
insufficient supply of oxygen in the body. Well-known human
conditions that cause anemia are thalassemias, sickle cell anemia
and Fanconi anemia. The associated mutations affect hemoglobin or
cellular functions, which are crucial for erythrocyte development or
viability. Icefish usually have no erythrocytes, and do not use
hemoglobin for oxygen transport. Icefish have special
cardiovascular adaptations, which, combined with their relatively
low metabolic rates and the high solubility of oxygen in the low-
temperature water of their natural environment, ensure that their
tissues receive an adequate supply of oxygen (Sidell and O’Brien,
2006). Comparing the white-blooded icefish with closely related
species that produce hemoglobin and have erythrocytes has already
led to the identification of a candidate gene that could be involved
in determining the lack of erythrocytes in the former (Detrich and
Yergeau, 2004), and has contributed to a better understanding of
human red blood cell formation.
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Table 1. Features of evolutionary mutant models for human diseases 
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Cichlid fish: models of craniofacial developmental disorders
Freshwater fish from the family Cichlidae are a species-rich group
of fish that display an outstanding variety of morphological and
physiological adaptations to their specialized ecological niches.
Differences in what they eat and where they feed have led to a great
diversity in the morphology of the craniofacial skull, jaws and teeth
in many cichlid fish species (Fig. 4). Studies on the differences in
the development of structures that are responsible for these
morphological specializations can contribute to an improved
understanding of what goes wrong in medically important human
craniofacial variation.
Models for craniofacial diseases that involve distortions in the
construction of the face and jaw and dentition can be found among
cichlids, and these have been proposed to reveal new targets for the
prediction and treatment of human craniofacial disorders (Albertson
et al., 2009). One study has shown that allelic differences affecting
the Patched-1 (Ptc-1) gene are responsible for adaptive variation in
the shape of the lower jaw of Lake Malawi cichlid fish (Roberts et
al., 2011). Patched-1 is a component of the sonic hedgehog signaling
pathway, which has been shown to be involved in development of
the mammalian upper jaw, and thus PTCH1 could be a reasonable
candidate gene for craniofacial disorders in humans (Cobourne and
Green, 2012; Young et al., 2010). In line with this, a role for sonic
hedgehog signaling in jaw development has been discovered in
zebrafish (Eberhart et al., 2008), which nicely demonstrates the
complementary nature of studies in non-mainstream model species.
Whereas the Antarctic fish and cichlid models described above
are clearly the result of positive selection, the adaptive value of the
disease-like phenotype in cave-dwelling fish and short-lived fish,
which are discussed below, is less obvious, and might be the result
of neutral or even regressive evolution.
Blind cavefish: models of retinal degeneration, albinism and sleep
disorders
The blind cavefish, Astyanax mexicanus, has traditionally been a
source of fascination for evolutionary biologists, and its potential for
illuminating disease phenotypes and their molecular basis has been
recognized more recently. Like other animals that inhabit the
lightless habitats of caves, Astyanax fish have, during their
evolution, undergone degeneration of light-sensing organs and loss
of pigmentation. In cavefish evolution, living in the dark has
repeatedly and independently led to degenerated lenses and retinas
(Fig. 5), resulting in a striking similarity to human retinal
degradation disease symptoms.
The Mexican cavefish Astyanax is unique in that surface
populations (living in light conditions) and cave populations co-exist
and thus can be subjected to comparative studies (Borowsky and
Wilkens, 2002; Gross, 2012; Strecker et al., 2003; Wilkens, 2010).
Previous studies have indicated that differential regulation of certain
eye development genes (e.g. pax6, sonic hedgehog) are linked to the
eye degeneration process (Jeffery, 2009); however, these factors
probably act as downstream mediators for so-far-unidentified mutant
genes that initiate degeneration in these fish (Wilkens, 1988). QTL
analysis has identified several loci that are involved in eye
degeneration (O’Quin et al., 2013; Protas et al., 2007), but the genes
encompassed by these loci are not yet known. Clearly, the full
genome sequence of Astyanax, which is in the process of being
deciphered (Wesley Warren, Washington University School of
Medicine, personal communication), and detailed genetic maps are
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Fig. 3. Representative Antarctic notothenioid fish. The Antarctic rockcod,
Notothenia coriiceps (top), is red-blooded and possesses a robustly
mineralized skeleton. The white-blooded icefish, Chaenocephalus aceratus
(bottom), is profoundly anemic and osteopenic. Photographs provided by H.
William Detrich (Northeastern University).
Fig. 4. Cichlid fish have evolved different craniofacial morphologies
according to the diet to which the respective species has specialized.
This has led to differences in the morphology of the skull, and particularly the
jaws. Interestingly, similar ecological adaptation has repeatedly led to the
evolution of similar morphologies in different cichlid lineages. The picture
shows similar ecomorphs from Lake Tanganyika (left) and Lake Malawi
(right). Reproduced with permission (Albertson and Kocher, 2006), and

















necessary to pinpoint the affected genes and clarify their role in eye
development.
Human pigmentation disorders are sometimes regarded to be of
‘cosmetic’ relevance alone; however, some conditions such as
albinism or vitiligo have been linked to severe psychological
problems. Moreover, light skin is predisposed to skin cancer, and the
absence of melanin in the retina can cause vision problems. A gene
that is mutated in the melanin-less cavefish is OCA2, encoding an
endoplasmic reticulum (ER)-localized transporter; the same gene
has been shown to cause oculocutaneous albinism type II in humans
(Protas et al., 2006). This provides a proof-of-principle example that
mutations in the same gene can cause the same phenotype in human
and fish.
The diurnal change of darkness and light is known to synchronize
the periods of activity and sleep, and changes in the external
zeitgeber seriously affects the ability to sleep, as everyone who has
experienced jet lag will agree. In cave habitats, the daily
environmental cues from light are absent, so the cave-dwelling
Astyanax mexicanus populations have developed symptoms of sleep
loss. Sleep disorders in humans include insomnia, advanced or
delayed sleep phase syndrome, jet lag and shift-worker sleep
disorder. Diverse neurotransmitter systems have been implicated in
regulating sleep of mammals (Cirelli, 2013). In cavefish,
physiological studies have revealed that blockade of β-adrenergic
receptors with propranolol rescues the decreased-sleep phenotype.
These findings indicate an involvement of β-adrenergic or NMDA
receptor signaling (Duboué et al., 2012). The fact that different cave
populations evolved the derived sleep loss independently through
convergent mechanisms (Duboué et al., 2011) promises a wealth of
information on possible molecular causes for the same phenotype of
reduced sleep. Many different genes and pathways are expected to
be involved in sleep regulation and it can be expected that, in the
different cave populations, different genes have been mutated, each
leading to disturbance of sleeping behavior.
Annual killifish: models for aging
Killifish are mostly small species of freshwater fish belonging to the
order Cyprinodontiformes. Some killifish species have adapted to
the severe ecological conditions provided by temporary ponds of the
wet-dry tropical savannas. Their eggs and embryos survive the dry
period in a stage of diapause in the soil, and hatch when the rainy
season starts. The whole life cycle is then completed in the few
months before the ponds dry out. Thus, most annual killifish have a
short lifespan, even in the aquarium. This feature makes them
superior models for aging research, because the other fish models
under the same optimal conditions of aquarium care can live for
several years, e.g. zebrafish reach an age of 6 years. In particular,
the turquoise killifish Nothobranchius furzeri has been developed as
an aging model (Terzibasi et al., 2007). Strains with different
lifespans exist, the shortest being only 10 weeks and the longest 31
weeks from hatching to natural death. Aging fish show many
general features of old organisms, including decreased fertility,
cognitive decline, expression of age-related molecular markers and
high morbidity. The availability of genotypes of N. furzeri that differ
in average lifespan allows loci that control lifespan to be mapped by
QTL analysis (Kirschner et al., 2012).
In N. furzeri, aging is connected to an increased risk of a number
of diseases, including cancer, infectious diseases, circulation
problems and neural degeneration. Why the aging organism displays
this multimorbidity phenomenon is a question for which N. furzeri
will provide a useful model.
Toadfish: models of hepatic encephalopathy and sickle cell anemia  
The toadfish (Batrachoididae) are bottom dwellers that graze the
sediment for worms, crustaceans, mollusks and other fish. Being
slow movers and poor swimmers, they have evolved multiple
strategies to hide from predators. One is to limit chemosensory
signals, which is accomplished by the release of large amounts of
urea to mask the scent of the toadfish. The excessive production of
urea and a rather unique nitrogen excretion pattern makes toadfish
extremely resistant to ammonia challenge, which is a threat to
human health. Thus, toadfish, and in particular one well-studied
species, the plain midshipman Porichthys notatus, have been
proposed as a model for a human disease known as hepatic or
portosystemic encephalopathy, which is due to liver failure (Walsh
et al., 2008). The malfunction of the liver leads to confusion, altered
levels of consciousness, coma and ultimately to death. One main
cause of hepatic encephalopathy is excessive nitrogen load, e.g.
following renal failure or due to inborn errors of the urea cycle.
Toadfish could also provide models for sickle cell anemia. A point
mutation in human β-globin leads to the formation of a malfunctional
hemoglobin known as HbS, which aggregates under low-oxygen
conditions and consequently distorts erythrocytes to a sickle shape.
Because these mutant cells confer a key adaptive advantage, namely
resistance to malaria, the mutation is one of the most prevalent human
inherited disorders. The toadfish hemoglobin behaves similar to the
mutant HbS under hypoxia and induces a sickle-cell-like trait (Hárosi
et al., 1998). The ordered aggregates in the red blood cells are
remarkably similar in their biophysical features to those in human
erythrocytes that contain HbS. Therefore, toadfish hemoglobins
provide a useful tool for studying sickling disorders and other protein-
aggregation-related phenomena. Interestingly, bottom-dwelling
toadfish are virtually sessile and do not necessarily experience oxygen
shortage, so the potential adaptive value of this trait is unclear. The
feature might have developed as a neutral character.
The relatively big, raptorial, marine batrachoid fish might intuitively
not look like a very good laboratory model, but the hardy adults are
readily maintained in many laboratories, and eggs and larvae are also
easily accessible and available. A species of toadfish has even joined
zebrafish, medaka and Xiphophorus as an experimental organism
aboard a space shuttle, demonstrating its robustness.
Medical condition models
Several fish models that develop the same disease as are seen in
humans have been established. The condition leads to sickness in
those individuals, which is different from the situation in the models
REVIEW Disease Models & Mechanisms (2014) doi:10.1242/dmm.012245
Fig. 5. Two epigean Mexican tetras (Astyanax mexicanus) and their eye-
less unpigmented cave-dwelling relative. Photo provided by Richard
















described above where adaptations to the environment have resulted
in disease-like phenotypes in healthy individuals. Some of these
models also have additional features that are adaptive for the fish
under natural conditions but mimic a human disease, in the same
way as the evolutionary mutant models.
Xiphophorus: models of melanoma and disorders connected to
development of sexual maturity
Xiphophorus fish are one of the oldest animal models for cancer
research (Heston, 1982) and the first to provide evidence that cancer
has a genetic component. Early in the last century, it was found that
certain hybrids of platyfish (Xiphophorus maculatus) and swordtails
(X. hellerii) develop a highly malignant pigment cell tumor
classified as melanoma (Gordon, 1927; Häussler, 1928; Kosswig,
1928). Xiphophorus is qualified as a true evolutionary mutant model
because the malignant skin cancers develop from naturally occurring
large pigment spots that are found in several species of this group
of fish and have a function in kin recognition and mate choice
(Fernandez and Bowser, 2010; Franck et al., 2001). Those spot
patterns develop on the basis of an elaborate genetic interaction of
a melanoma locus (Tu), whose activity is downregulated by a tumor
suppressor locus (R or Diff) so that only large nevus-like spots occur,
which never grow out to melanoma – with extremely rare exceptions
(Schartl et al., 1995). Based on the fact that Tu and R are on different
chromosomes, a crossing scheme can be set up to substitute the
tumor-suppressor-containing chromosome pair by tumor-suppressor-
free chromosomes of a closely related species that does not have the
Tu/R system. In the hybrids, in the absence of R, the oncogene can
manifest its deleterious function and highly malignant melanoma
develop (Meierjohann and Schartl, 2006; Schartl, 2008) (Fig. 6).
Besides this ‘classical’ crossing (the Gordon-Kosswig-Anders
melanoma), a number of other melanoma models have been
developed in Xiphophorus (Patton et al., 2010).
A candidate gene for the R locus is the Xiphophorus homolog of a
cyclin-dependent kinase inhibitor, CDKN2A/B. Inactivation of the
CDKN2A gene is a rare but highly penetrant risk factor for human
familial melanoma (Meyle and Guldberg, 2009) and is also associated
with many other cancers. The critical oncogene encoded by the Tu
locus is xmrk, which encodes a mutationally activated version of the
fish epidermal growth factor receptor (EGFR). Oncogenic signaling
by EGFR and other related receptor tyrosine kinases is a hallmark of
many tumors, including melanoma. In light of this, the Xiphophorus
fish model has become a widely used system to study the genetics and
molecular biology of melanoma formation. Studies on the tumor-
inducing function of Xmrk in fish melanoma, complemented by
analyses using established mouse and human cell culture systems in
which xmrk was introduced as a transgene, have revealed important
insights. For instance, the now well-established fact that the majority
of human melanoma harbor mutations that confer constitutive activity
to the Ras-Raf-MAPK signaling pathway was noted early on in the
Xiphophorus system (Wellbrock and Schartl, 1999). Oncogenic
signaling by Xmrk also activates the cytoplasmic Src-kinase Fyn
(Wellbrock and Schartl, 1999; Wellbrock and Schartl, 2000), and the
signal transducer and transcription factor Stat5 (Baudler et al., 1999;
Morcinek et al., 2002), which prompted studies of these molecules in
the context of human melanoma. These studies revealed roles of Fyn
and Stat5 in proliferation, apoptosis, dedifferentiation and cell
migration. Remarkably, Stat5 seemed to play an unexpected role in
melanoma resistance to interferon α (IFNα) therapy (Wellbrock et al.,
2005), which is a common problem in the treatment of human
melanoma. Another Xmrk-regulated effector molecule, osteopontin
(Geissinger et al., 2002), has been identified as a plasma marker for
melanoma progression (Kluger et al., 2011; Zhou et al., 2005) and is
now in use in the clinic. Crucial tasks for the near future are the firm
identification and characterization of pathways involved in melanoma
suppression.
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Platyfish (parental strain) Hybrid (offspring)
Cross with swordtails Fig. 6. Development of melanoma in hybrid
offspring of platyfish and swordtails. 
(A-C) Platyfish (Xiphophorus maculatus) with
different pigmentation patterns are shown.
(D,E) After crossing with swordtails (X. hellerii),
offspring of A and B develop malignant
melanoma. (A) This fish has pigment spots in
the dorsal fin; (D) in the hybrids, which carry the
Sd (spotted dorsal) allele of Tu and a closely
linked tumor modifier, mdl, which determine the
onset and compartment of pigment spot or
melanoma formation, respectively, melanoma
formation spreads out from this compartment.
(B) This platyfish has black spots on the flanks
determined by the Sp (spotted) allele of Tu and
its linked mdl; (E) hybrids consequently develop
melanoma from the body sides. Note that the
dorsal fin of this fish is free of melanoma cells,
which is different from the fish in D. (C,F) The
fish in C carries the Sr (striped) allele of Tu
along with mdl, which are not tumorigenic in the


















An important aspect of this fish model is the fact that tumor-
modifier genes have been defined via classical crossing experiments
(Meierjohann and Schartl, 2006). Tumor-modifier genes are genetic
determinants that are not involved in the primary events of
neoplastic transformation as classical oncogenes or tumor-
suppressor genes yet critically influence the course of the disease.
They determine, for instance, whether the same cancer will be fatal
for the individual or have a relatively mild progression. It will
certainly be of high interest to unravel the molecular nature and the
mode of action of these tumor-modifier genes from Xiphophorus
and to extrapolate the findings to human homologs.
Other hybrid genotypes of Xiphophorus do not develop melanoma
spontaneously and instead require UV irradiation (Mitchell et al.,
2007). Studies on the radiation-induced tumors in fact have led to
better definition of the hazardous UV spectrum and, in conjunction
with data from mammalian models, have shown that prolonged
chronic UV-A exposure does not contribute to melanomagenesis
(Fernandez et al., 2012). In other crosses, the hybrid fish can be
highly susceptible to develop other types of cancer following
treatment with chemical carcinogens, allowing the study of genetic
risk factors connected to susceptibility (Mitchell et al., 2007; Walter
and Kazianis, 2001).
Xiphophorus fish also provide a model for diseases connected to
impaired regulation of food uptake, energy balance and the onset of
sexual maturity. In many species, males attain sexual maturity when
they reach a certain stage of development that is defined by a
particular body weight and size and correlates with age. Once this
is accomplished, the males fully develop the secondary sex
characters and cease to grow further in size. The period of puberty
in Xiphophorus is genetically determined by a polymorphic locus,
the P-locus, and leads to either small, early-maturing males or large,
late-maturing males, or a continuum of intermediate size classes.
This link between puberty and energy balance is intriguing from a
medical point of view because it is known for instance that anorexia
nervosa in young girls goes along with delayed puberty whereas
early childhood obesity leads to premature menarche. The onset of
puberty in Xiphophorus is determined by copy-number variation
affecting the melanocortin 4 receptor at the P-locus (Lampert et al.,
2010). This receptor is known to play a crucial role in the very
complex network that controls food uptake and energy balance in
humans, and mutations in this receptor are connected to obesity and
early-onset puberty. The evolutionary model of genetically
controlled puberty in Xiphophorus provides a novel tool to analyze
this multicomponent system, which integrates signals not only from
the hypothalamic melanocortin 4 receptor system but also from
adipose tissue, via leptin, and thereby links the nutritional status to
reproduction.
The Xiphophorus model is currently ahead, from a logistics point
of view, of all the other evolutionary models because it offers a
number of resources for the community. The genome is sequenced
(Schartl et al., 2013) and available on the EMSEMBL genome
server (http://uswest.ensembl.org/Xiphophorus_maculatus/Info/
Index), cell lines have been developed, and a genetic stock center at
the University of San Marcos (http://www.xiphophorus.txstate.edu/)
provides inbred lines and strains derived from natural populations,
as well as comprehensive information on protocols, genetic maps
and reference databases.
Eels: models of physiological bone demineralization and childhood kidney
cancer
Eels, members of the Anguilliformes order, are characterized by an
elongated body axis. Understanding how changes in the embryonic
program for the production of additional segments of the body
(somites) that form cartilage, muscle and bone are brought about in
eels could enable a better understanding of pathological changes that
affect these structures in a variety of human disorders and diseases.
Somitogenesis has been studied using a loss-of-function (i.e.
mutagenesis) approach in zebrafish and medaka (genes were
identified because interfering with their function led to loss of
somites), but eels provide an opportunity to examine this process in
a gain-of-function model (the identification of genes based on the
formation of additional somites). Eels have also lost their pelvic fins,
which are homologous structures to the hindlimbs of tetrapods
(Burke and Rosa-Molinar, 2002). Deformations of legs affect several
tens of thousands of humans every year, and the underlying
developmental and molecular mechanisms are barely understood.
Eels are also known to undergo bone resorption in situations of
physiological stress, for instance during fasting or during their
extensive migrations for reproduction. Thyroid hormone has been
shown to be involved in demineralization of bone in eels (Sbaihi et
al., 2007), and an overproduction of the same hormone in humans can
induce bone loss and osteoporosis. The cellular and molecular
mechanisms of thyroid hormone action in bone remain, however,
controversial (Nicholls et al., 2012). The eel therefore provides a
complementary model to mammalian models for the study of
osteoporosis in humans, and could contribute to a better understanding
of the action of thyroid hormone and bone demineralization.
Last but not least, eels are a natural model for Wilms’ tumor
(Masahito et al., 1992), a malignant kidney tumor that affects 1 in
10,000 children at early age. This tumor occurs ‘spontaneously’ with
high prevalence in these fish in the wild. Such a natural model is not
available elsewhere, and previous studies have relied on a somewhat
complicated and highly engineered transgenic mouse model (Hu et
al., 2011).
The Amazon molly: a clonal model
The Amazon molly, Poecilia formosa, stands out from all other
vertebrate aquatic models by virtue of its unique feature of genetic
clonality (Lampert and Schartl, 2008), which is a result of its
unusual mode of reproduction. Females produce diploid eggs
without meiosis; in response to sperm of males from related species,
the eggs then undergo parthenogenesis. There is, however, no
paternal genetic contribution and all offspring develop as clones of
their maternal lineage. Many different clones exist in nature (Stöck
et al., 2010). The proven true clonality of lines maintained in the lab
allows researchers to perform experiments with animals that are
genetically identical. This guarantees utmost reproducibility of
independent studies, a stereotypical development of diseases or
physiological processes under scrutiny and the generation of highly
comparable biological material. Importantly, studies in a natural
clonal vertebrate allow disease phenotypes and underlying
mechanisms to be studied without the influence of the genetic make-
up of the experimental animal. Such questions are generally barely
understood and cannot be addressed in a similar way in vivo in any
other vertebrate disease model. Thus far, the Amazon molly has
been used for studies on melanomatous skin cancers (Schartl et al.,
1997), thyroid cancer (Woodhead et al., 1984) and infectious
diseases (Tobler and Schlupp, 2005), but it is hoped that a much
broader spectrum of disease models can be developed.
Damselfish: models of cancers caused by viruses and of
neurofibromatosis
An estimated 15% of all human cancers worldwide might be
attributed to viruses (Liao, 2006). The study of viruses that cause
















tumors in animals has contributed essential information to our
understanding of the molecular biology of cancer genes. The
majority of tumors caused by DNA viruses and retroviruses are
papillomas, sarcomas, lymphomas and leukemias (Fan, 1994).
Damselfish neurofibromatosis (DNF) is an example of a naturally
occurring tumor affecting neuroectodermal cells, and is caused by
an as-yet-unknown transmissible virus-like agent (Rahn et al.,
2004). DNF is a disease that naturally affects bicolor damselfish
Stegastes partitus (Fig. 7) on Florida reefs. It is characterized by the
development of multiple neurofibromas, malignant peripheral nerve
tumors and pigment-cell tumors (Schmale et al., 1983; Schmale et
al., 1986). Its characterization is important because it could be
representative of a potential new class of tumor-inducing-
transmissible agents.
Mummichog and the sheepshead minnow (killifish): models for
environmental toxicology
The disease models discussed so far can be used to obtain a better
understanding of the mechanisms of disease development and to
improve diagnosis and therapy. However, some fish that are afflicted
by the same diseases as humans have evolved features that make
them resistant to such diseases, in particular those evoked by
toxicants from the environment. The mummichog Fundulus
heteroclitus inhabits a wide range of mainly brackish, but also
freshwater and marine, habitats all along the North American east
coast from northern Florida to Canada. This fish shows an enormous
plasticity and occupies diverse ecological niches. Some populations
have evolved tolerance to hypoxia, extreme tolerance to high or low
temperature and, most interestingly, tolerance to pollution coming
from industrial, agricultural and municipal sources. Thus, this fish
is potentially amenable to toxicogenomics analyses to gain insight
into the processes of toxicant uptake, metabolism and toxicity. As a
relatively small fish that can be maintained and bred in the
laboratory, Fundulus has already served as a biological model in
many other areas, including embryology, physiology, ecology and
evolution (Burnett et al., 2007). Thus, its physiology, and molecular
and developmental biology are well understood. From a human
health standpoint, the mummichog has been used as a model for the
study of physiological resilience and adaptations (Burnett et al.,
2007). The adaptations to different salinity involves ion channels
and transporters; thus, diseases or physiological processes in which
such molecules are involved (e.g. osmoregulation, cystic fibrosis,
cardiac physiology) could benefit from studies in Fundulus.
Inhabiting similar environments as the mummichog, but farther
southwards, and belonging to the same order of fish
(Cyprinodontiformes), the sheepshead minnow (Cyprinodon
variegatus) is similarly adapted to fluctuating environmental
conditions. Owing to their hardiness and the ease with which they can
be maintained and bred in the laboratory, they have been commonly
used in toxicology experiments (Hinton et al., 2005). Like the
mummichog, this fish has been developed as a model for studies on
xenobiotic exposure and human intoxication (Hinton et al., 2005).
Rainbow trout: models of liver cancer induction by environmental
carcinogens
The rainbow trout (Oncorhynchus mykiss) is one of the oldest
animal models for human cancer, in particular liver cancer. This
species has a remarkable sensitivity to environmental carcinogens.
In fact, the human liver carcinogen aflatoxin B1 produced by the
common mold Aspergillus was first identified in 1960 when an
epizootic outbreak of hepatoma was noted in trout hatcheries in
California after fish had been fed with molded cottonseed flour
(Jackson et al., 1968). The histopathology of trout liver cancer is
strikingly similar to that in humans. As in humans, mutations in the
KRAS oncogene are also common in trout liver cancer, and changes
in the gene expression program in response to liver damage are
comparable between the human and rainbow trout. After becoming
an established model of liver cancer induction, these fish were used
to identify many other environmental chemicals with a tumor-
inducing or tumor-promoting effect. More recently, strategies were
also developed for cancer chemoprevention (Williams, 2012).
Dietary supplements were tested and some that efficiently inhibit
liver cancer initiation following exposure to e.g. aflatoxin were
identified. Trouts have key unique advantages in such studies; for
instance, several tens of thousands of fish can be screened to
determine dose-response relationships at levels orders of magnitude
lower than is possible in rodents. In addition to being an
economically important aquaculture species, a wealth of knowledge
about trout biology, biochemistry, molecular biology and genetics
exists. Although more tedious than in the small laboratory fish
owing to the organism’s lengthy generation time, methods to create
transgenic and knockout models have been established. Thus, it is
possible and reasonable to develop other human disease models
based on the rainbow trout, in particular other cancers.
Conclusions and outlook
The value and advantages of the naturally occurring evolutionary
mutant models can hardly be summarized in one sentence. It is clear
that there are few unifying characteristics besides those that lie in
the concept of the evolutionary mutant model itself. Each fish
species reviewed here presents with only one or very few disease-
related phenotypes. However, these offer the opportunity to ask
questions about this particular disease in a different way than in the
traditional ‘genetically domesticated’ models. Finding molecules,
mechanisms and aberrations that are evolutionarily conserved
between fish and humans gives a strong indication that they are truly
relevant to a given disease. In addition, studying the mutant models
in their natural habitats, or modeling certain aspects of their life
history in the laboratory, enables assessment of environmental
influences on the symptoms and course of diseases.
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Fig. 7. Healthy and diseased bicolor damselfish
(Stegastes partitus). (A) Healthy; (B) diseased.
The diseased fish shows several pigmented lesions
(chromatophoromas) and a non-pigmented
neurofibroma in the corner of the mouth. Photos

















Also in the case of the classical fish disease models, zebrafish and
medaka, researchers are starting to make use of wild-caught strains,
which can be evaluated for evolution-driven mutations. In medaka,
a number of highly inbred strains have been established, which are
derived from different natural populations or laboratory fish stocks.
This provides a unique genetic resource that can be used to study
natural allelic variation of disease-modifier genes.
One example in which genetic variation that is fixed in a panel of
inbred lines gives important information on disease-modifier genes
is a transgenic melanoma model in medaka (Schartl et al., 2010).
Here, the melanoma-inducing xmrk oncogene from Xiphophorus
under control of a medaka promoter (from the pigment-cell-specific
mitfa gene) is expressed specifically in pigment cells. As described
earlier, Xiphophorus spontaneously develop malignant melanoma
with high penetrance. Interestingly, when the same transgene is
expressed in various inbred strains, depending on the genetic
background, different types of tumor can result: highly invasive and
metastasizing fatal melanoma from extracutaneous sites; much less
life-threatening, large exophytic masses of tumors on the
integument; or malignant melanoma of the uvea (Schartl et al.,
2010). These distinct types display different gene expression
signatures (Schartl et al., 2012), which can be ascribed to the
presence of different tumor-modifier genes or allelic variation in the
different strains. Whole-genome sequencing of these strains and a
large panel (approximately 200) of near-isogenic strains established
from a single wild population of medaka will provide a unique
resource to identify disease-modifier genes and to analyze the
interplay between natural genetic variation and disease (Spivakov et
al., 2013).
There is a technological aspect that also contributes considerably
to the renaissance of evolutionary mutant models. New sequencing
technologies now enable full genomic resources to be produced at
low cost, even by very small consortia, which will allow the study
of disease processes in those models at the molecular level – an
opportunity that until recently has existed only for a handful of
carefully selected mainstream models. Consequently, the genomes
and transcriptomes of several of the evolutionary models are
currently fully sequenced or top-listed for the near future (Table 1).
Zebrafish and medaka have optimal features for conducting large-
scale drug screens. For technical reasons, this has been developed
for embryonic phenotypes. However, when it comes to adult
phenotypes, at least some of the evolutionary models will provide
powerful complementary platforms for drug screening.
One of the values of the zebrafish and medaka models is the ease
with which transgenic fish can be produced; in addition, target genes
can be readily inactivated in these species. In this respect, the
evolutionary models are lagging behind. Proof-of-principle evidence
has been reported for the turquoise killifish, for which stable GFP-
expressing lines were generated (Hartmann and Englert, 2012).
Hence, it can be assumed that this technology, as well as the more
demanding gene-knockout approaches, will also be possible in the
other killifish models, and probably in all freshwater fish species. In
other species, such as live-bearing fish (Xiphophorus and Poecilia
species) or the marine models, for which the development of
transgenic fish is more complicated, this might not be accomplished
in the foreseeable future. However, as previous examples have
shown, evolutionary mutant models can be combined with
established laboratory models for functional and translational
studies, e.g. by expressing the gene of interest from the evolutionary
model as a transgene in zebrafish and medaka, or by knocking down
the zebrafish or medaka homolog (Schartl et al., 2010; Yergeau et
al., 2005).
Another alternative for the evolutionary models might come from
the possibility of performing large-scale screens with small-
molecule libraries. Compounds that drive a knockdown of a
particular protein could be used for functional studies also in those
species for which transgenic technologies are not available.
Intuitively, taking the evolutionary models out of the field and
doing experiments on laboratory-raised offspring or even established
lines might seem to diminish their value, particularly in terms of
genetic diversity. However, laboratory lines are useful for the
isolation, conservation and in-depth study of certain alleles or allele
combinations that are relevant to the development of a disease
condition.
A general weakness in the fish field is the minimal availability or
even complete lack of cell culture systems. Even for widely used
models, only a handful of superficially characterized cell lines exist.
The importance of defined in vitro systems for in-depth molecular
analyses and for complementation of functional studies is
paramount. Although there are now several examples where the
biochemistry and cellular functions of fish proteins have been
studied successfully in mammalian cells, there is a clear need to
generate more cell lines from various tissues from the mainstream
fish models, and particularly for the evolutionary mutant models.
Progress in the fish field also depends, to some extent, on the
availability of experimental reagents. Reagents for analytical and
functional studies at the nucleic acid level can now be produced with
relative ease for almost any organism by any lab. However, the
prime tool for protein studies, the analytical antibodies, are much
more demanding to produce and a single research team can generate
only a handful of them, at best. The large array of commercially
available antibodies for mammalian models, and increasingly also
for zebrafish, only evoke envy by those that study other fish species.
This important gap will be difficult to seal in the near future, and
researchers might have to rely on cross-reacting antibodies from
zebrafish in the short term. Sharing reagents and relevant
information (as well as other data) can be the tasks of a central fish
model database, and should motivate the field to build up a network
of researchers that work on non-mainstream models.
The traditional approach in the domesticated models is to generate
‘artificial’ variation in the laboratory by mutagenesis. Nonetheless,
natural selection is a potent generator of variation as well. Fish are
extremely bio-diverse and make up more than half of the known
60,000 vertebrate species. It could be argued that variation among
wild fish species far exceeds the variation that has been generated
in the laboratory. The little that we know about almost all those fish
species should encourage us to carefully look out for the multitude
of novel evolutionary mutant models that surely exist, and that will
help to improve our understanding of human diseases, their
diagnosis and treatment.
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